# Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

> **NCT02176850** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 19870 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Micardis®

## Key facts

- **NCT ID:** NCT02176850
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** 2000-05
- **Final completion:** —
- **Target enrollment:** 19870 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176850, "Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02176850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*